Sanofi unit gets 40 brands, 750 Indian staffers in buyout

Sanofi ($SNY) and United Medicare agreed on a buyout deal that would give the French drugmaker's Indian unit Aventis Pharma 40 over-the-counter nutraceutical brands and 750 of Universal Medicare's employees. The acquisition will allow Sanofi to reach "large sections of India's population through...pharmaceuticals, vaccines and now nutraceuticals," Aventis managing director Shailes Ayyangar said. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.